What is VTRS's current stock price?

VTRS is currently trading at $16.07 with a daily change of +0.72%. Visit StocksRunner for live updates.

What are VTRS stock's key strengths?

VTRS current strengths include: Trading below its fair value, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with VTRS stock?

Current risk factors for VTRS include: Low. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is VTRS's current StocksRunner IQ Score?

VTRS current StocksRunner IQ Score is: Strong Buy. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence VTRS's StocksRunner IQ Score?

VTRS StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

<

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

VTRS Stock Analysis & IQ Rating | Viatris

Q: Should I buy VTRS stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for VTRS aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Strong Buy. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for VTRS?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in VTRS near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

VTRS

Viatris

$16.07

+$0.12 | +0.72%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$16.43

MKT CAP

$18.50B

52W Low

$6.85

VOL

$14.68M

P/E Ratio

N/A

AVG VOL

$9.51M

RSI

78.66

TREND

Uptrend

VTRS Stock IQ

Login to see Viatris (VTRS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VTRS Target Price

Login to display

Strengths

VTRS Rewards

Upgraded on attractively valued

VTRS Rewards

Trading below its fair value

Risk Analysis

VTRS Risk Analysis

Investors losing their confidence

VTRS Price Performance

$12.97 (+23.90%)

$10.69 (+50.33%)

$10.09 (+59.27%)

$9.24 (+73.92%)

1year

6month

3month

1month

VTRS Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

VTRS Analysts opinion is positive and also has improved from the past 3 months

VTRS Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

80%

Consensus Rating

75%

Buy
Opinion

100%

Trend
Score

100%

Potential
Score

VTRS Street Sentiment is extremely bullish and have positive views on the near-term outlook

VTRS Risk Level

VTRS has Low risk level

Low

LOW

HIGH

VTRS Performance Sentiment

Sentiments overview associated with events and the stock performance

80%

Positive

12 out of 15
events present

7%

Negative

1 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$12.97

Resistance Price

$16.13

Current Price Range

$16.07

$12.97

$16.13

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Consensus Rating

STRONG BUY

5

Buy

0

Hold

0

Sell

Date

Action

Rating

Firm

Feb 18, 2026

Upgrade

Buy

UBS

Feb 09, 2026

Upgrade

Buy

UBS

Jan 06, 2026

Upgrade

Buy

Zacks

Dec 30, 2025

Initiate

Buy

Barclays

Dec 10, 2025

Initiate

Overweight

Barclays

Runners Also Watch

Close Price

Change

TBPH

Theravance Biopharma

19.06

-1.04%

PRFX

PainReform Ltd.

2.89

-3.02%

PFE

Pfizer

27.14

+0.30%

NVS

Novartis AG

167.11

+1.46%

INDV

Indivior PLC

33.06

+0.39%

VTRS Latest Analysis +

Unveiling Viatris (VTRS) Q4 Outlook: Wall Street Estimates for Key Metrics. Evaluate the expected performance of Viatris (VTRS) for the quarter ended December 2025 looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Mon Feb 23, 2026

$15.95 | +0.19%

Earnings

Viatris Stock to Report Q4 Earnings: Whats in the Cards?. VTRS gears up for Q4 results amid Indore import alert segment revenue pressure and steady margins as shares surge 39.7% in a year.

Mon Feb 23, 2026

$15.95 | +0.19%

Momentum

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline. Viatris (VTRS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Feb 19, 2026

$15.98 | -0.44%

Earnings

UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade. Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11. The company’.s stronger [….]

Wed Feb 18, 2026

$16.05 | +1.97%

Potential

Rating

Viatris (VTRS) Shares Cross 3% Yield Mark. Looking at the universe of stocks we cover at Dividend Channel in trading on Thursday shares of Viatris Inc (Symbol: VTRS) were yielding above the 3% mark based on its quarterly dividend (annualized to $0.48) with the stock changing hands as low as $15.79 on the day. Dividen

Thu Feb 12, 2026

$15.79 | -2.11%

Activity

Where is Viatris Inc. (VTRS) Headed According to the Street?. Viatris Inc. (NASDAQ:VTRS) is one of the best healthcare stocks under $50 to invest in. Viatris Inc. (NASDAQ:VTRS) received a rating update from Piper Sandler on January 28 which adjusted the price target on the stock to $12 from $9 while maintaining a Neutral rating on the shares. The rating

Tue Feb 10, 2026

$15.95 | +2.51%

Activity

Potential

Rating

Viatris gains as UBS upgrades to Buy on outlook and pipeline.

Mon Feb 9, 2026

$15.56 | +6.72%

Momentum

Rating

FAQ About VTRS Stock Insights

What is VTRS current stock price?

What are VTRS stock strengths?

What is VTRS Risk Level?

What is VTRS market cap and volume?

What is VTRS current Stock IQ?

Should I buy VTRS stock right now?

Is VTRS a Strong Buy right now?

What does a 'Strong Buy' rating mean for VTRS?

What does a 'Strong Sell' rating mean for VTRS?

What factors influence VTRS's Stock IQ?

Explore our VTRS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored VTRS Stock Strategies
Effective Risk Management

FIND US ON

Receive our VTRS Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

VTRS

Viatris

Set Alerts

Current Price

$16.07

+$0.12 | +0.72%

52W High

$16.43

MKT CAP

$18.50B

52W Low

$6.85

VOL

$14.68M

P/E Ratio

N/A

AVG VOL

$9.51M

RSI

78.66

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

TBPH

Theravance Biopharma

19.06

-1.04%

PRFX

PainReform Ltd.

2.89

-3.02%

PFE

Pfizer

27.14

+0.30%

NVS

Novartis AG

167.11

+1.46%

INDV

Indivior PLC

33.06

+0.39%

VTRS Price Performance

$12.97 (+23.90%)

$10.69 (+50.33%)

$10.09 (+59.27%)

$9.24 (+73.92%)

1year

6month

3month

1month

VTRS Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

VTRS Analysts opinion is positive and also has improved from the past 3 months

VTRS Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

80%

Consensus Rating

75%

Buy
Opinion

100%

Trend
Score

100%

Potential
Score

VTRS Street Sentiment is extremely bullish and have positive views on the near-term outlook

VTRS Risk Level

VTRS has Low risk level

Low

LOW

HIGH

VTRS Performance Sentiment

Sentiments overview associated with events and the stock performance.

80%

Positive

12 out of 15
events present

7%

Negative

1 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$12.97

Resistance Price

$16.13

Current Price Range

$16.07

$12.97

$16.13

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Consensus Rating

STRONG BUY

5

Buy

0

Hold

0

Sell

Date

Action

Rating

Firm

Feb 18, 2026

Upgrade

Buy

UBS

Feb 09, 2026

Upgrade

Buy

UBS

Jan 06, 2026

Upgrade

Buy

Zacks

Dec 30, 2025

Initiate

Buy

Barclays

Dec 10, 2025

Initiate

Overweight

Barclays

VTRS Stock IQ

Login to unlock Viatris (VTRS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

VTRS Rewards

Upgraded on attractively valued

VTRS Rewards

Trading below its fair value

Risk Analysis

VTRS Risk Analysis

Investors losing their confidence

VTRS Latest Analysis

Unveiling Viatris (VTRS) Q4 Outlook: Wall Street Estimates for Key Metrics. Evaluate the expected performance of Viatris (VTRS) for the quarter ended December 2025 looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Mon Feb 23, 2026

$15.95 | +0.19%

Earnings

Viatris Stock to Report Q4 Earnings: Whats in the Cards?. VTRS gears up for Q4 results amid Indore import alert segment revenue pressure and steady margins as shares surge 39.7% in a year.

Mon Feb 23, 2026

$15.95 | +0.19%

Momentum

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline. Viatris (VTRS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Feb 19, 2026

$15.98 | -0.44%

Earnings

UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade. Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11. The company’.s stronger [….]

Wed Feb 18, 2026

$16.05 | +1.97%

Potential

Rating

Viatris (VTRS) Shares Cross 3% Yield Mark. Looking at the universe of stocks we cover at Dividend Channel in trading on Thursday shares of Viatris Inc (Symbol: VTRS) were yielding above the 3% mark based on its quarterly dividend (annualized to $0.48) with the stock changing hands as low as $15.79 on the day. Dividen

Thu Feb 12, 2026

$15.79 | -2.11%

Activity

Where is Viatris Inc. (VTRS) Headed According to the Street?. Viatris Inc. (NASDAQ:VTRS) is one of the best healthcare stocks under $50 to invest in. Viatris Inc. (NASDAQ:VTRS) received a rating update from Piper Sandler on January 28 which adjusted the price target on the stock to $12 from $9 while maintaining a Neutral rating on the shares. The rating

Tue Feb 10, 2026

$15.95 | +2.51%

Activity

Potential

Rating

Viatris gains as UBS upgrades to Buy on outlook and pipeline.

Mon Feb 9, 2026

$15.56 | +6.72%

Momentum

Rating

Discover VTRS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of VTRS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our VTRS Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VTRS Stock trends

VTRS Stock performance

VTRS Stock analysis

VTRS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VTRS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VTRS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

VTRS Stock Analysis & IQ Rating | Viatris

VTRS Stock IQ

VTRS Target Price

VTRS Analysts Opinion

VTRS Street Sentiment

VTRS Risk Level

VTRS Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our VTRS Stock insights

Receive our VTRS Daily Alerts

VTRS Street Sentiment

VTRS Risk Level

Key Price Levels

Latest Analyst Actions

Discover VTRS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of VTRS. We're here to help you make informed investment decisions today.

Receive our VTRS Daily Alerts

VTRS Alerts